Adenosine Carrier
Executive Summary
Pharmatec/Medco Research/University of Florida joint venture will develop and market therapeutic and diagnostic products consisting of a combination of adenosine and its derivatives in the patented Pharmatec carrier system. Joint venture company will conduct research into the Adenosine Carrier's ability to enhance the penetration of adenosine into the brain with the expectation of producing anti-convulsant, anti-anxiety, anti-depressant and hypnotic activity.